Non-small Cell Lung Cancer Therapeutics Market Report

Global and Region Non-small Cell Lung Cancer Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：216
  • REPORT CODE：GMM979392
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Non-small Cell Lung Cancer Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Non-small Cell Lung Cancer Therapeuticsmarket, defines the market attractiveness level of Non-small Cell Lung Cancer Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Non-small Cell Lung Cancer Therapeutics industry, describes the types of Non-small Cell Lung Cancer Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Non-small Cell Lung Cancer Therapeutics market and the development prospects and opportunities of Non-small Cell Lung Cancer Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Non-small Cell Lung Cancer Therapeutics market in Chapter 13.

    By Player:

    • Bristol-Myers Squibb

    • Pfizer

    • AstraZeneca

    • Novartis

    • Sanofi

    • Roche

    • GlaxoSmithKline

    • Eli Lilly

    By Type:

    • Alimta

    • Iressa

    • Avastin

    • Tarceva

    • Zykadia

    • Tagrisso

    • Xalkori

    • Cyramza

    • Opdivo

    • Alecensa

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Non-small Cell Lung Cancer Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Non-small Cell Lung Cancer Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Non-small Cell Lung Cancer Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Non-small Cell Lung Cancer Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Non-small Cell Lung Cancer Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Non-small Cell Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.2 United States Non-small Cell Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.3 Europe Non-small Cell Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.4 China Non-small Cell Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.5 Japan Non-small Cell Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.6 India Non-small Cell Lung Cancer Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Non-small Cell Lung Cancer Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Non-small Cell Lung Cancer Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Non-small Cell Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Non-small Cell Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Non-small Cell Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Non-small Cell Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Non-small Cell Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Non-small Cell Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Non-small Cell Lung Cancer Therapeutics Consumption Forecast (2022-2028)

    9 Global Non-small Cell Lung Cancer Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Non-small Cell Lung Cancer Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Alimta Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Iressa Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Avastin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Tarceva Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Zykadia Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Tagrisso Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Xalkori Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Cyramza Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Opdivo Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global Alecensa Consumption and Growth Rate (2017-2022)

    • 9.2 Global Non-small Cell Lung Cancer Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Non-small Cell Lung Cancer Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Non-small Cell Lung Cancer Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Alimta Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Iressa Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Avastin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Tarceva Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Zykadia Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Tagrisso Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Xalkori Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Cyramza Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Opdivo Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.10 Global Alecensa Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Non-small Cell Lung Cancer Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Non-small Cell Lung Cancer Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Non-small Cell Lung Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Non-small Cell Lung Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Non-small Cell Lung Cancer Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Non-small Cell Lung Cancer Therapeutics Market Competitive Analysis

    • 14.1 Bristol-Myers Squibb

      • 14.1.1 Bristol-Myers Squibb Company Details

      • 14.1.2 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Product and Service

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Details

      • 14.2.2 Pfizer Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Non-small Cell Lung Cancer Therapeutics Product and Service

    • 14.3 AstraZeneca

      • 14.3.1 AstraZeneca Company Details

      • 14.3.2 AstraZeneca Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 AstraZeneca Non-small Cell Lung Cancer Therapeutics Product and Service

    • 14.4 Novartis

      • 14.4.1 Novartis Company Details

      • 14.4.2 Novartis Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis Non-small Cell Lung Cancer Therapeutics Product and Service

    • 14.5 Sanofi

      • 14.5.1 Sanofi Company Details

      • 14.5.2 Sanofi Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Non-small Cell Lung Cancer Therapeutics Product and Service

    • 14.6 Roche

      • 14.6.1 Roche Company Details

      • 14.6.2 Roche Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Roche Non-small Cell Lung Cancer Therapeutics Product and Service

    • 14.7 GlaxoSmithKline

      • 14.7.1 GlaxoSmithKline Company Details

      • 14.7.2 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product and Service

    • 14.8 Eli Lilly

      • 14.8.1 Eli Lilly Company Details

      • 14.8.2 Eli Lilly Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eli Lilly Non-small Cell Lung Cancer Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Non-small Cell Lung Cancer Therapeutics

    • Figure Non-small Cell Lung Cancer Therapeutics Picture

    • Table Global Non-small Cell Lung Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Non-small Cell Lung Cancer Therapeutics Consumption by Country (2017-2022)

    • Figure United States Non-small Cell Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Non-small Cell Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Non-small Cell Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Non-small Cell Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Non-small Cell Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Non-small Cell Lung Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Non-small Cell Lung Cancer Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Non-small Cell Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Non-small Cell Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Non-small Cell Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Non-small Cell Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Non-small Cell Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Non-small Cell Lung Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alimta Consumption and Growth Rate (2017-2022)

    • Figure Global Iressa Consumption and Growth Rate (2017-2022)

    • Figure Global Avastin Consumption and Growth Rate (2017-2022)

    • Figure Global Tarceva Consumption and Growth Rate (2017-2022)

    • Figure Global Zykadia Consumption and Growth Rate (2017-2022)

    • Figure Global Tagrisso Consumption and Growth Rate (2017-2022)

    • Figure Global Xalkori Consumption and Growth Rate (2017-2022)

    • Figure Global Cyramza Consumption and Growth Rate (2017-2022)

    • Figure Global Opdivo Consumption and Growth Rate (2017-2022)

    • Figure Global Alecensa Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Alimta Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Iressa Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Avastin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tarceva Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Zykadia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tagrisso Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Xalkori Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cyramza Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Opdivo Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alecensa Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Non-small Cell Lung Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Non-small Cell Lung Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Non-small Cell Lung Cancer Therapeutics Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Non-small Cell Lung Cancer Therapeutics Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Non-small Cell Lung Cancer Therapeutics Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Non-small Cell Lung Cancer Therapeutics Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Non-small Cell Lung Cancer Therapeutics Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Non-small Cell Lung Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Non-small Cell Lung Cancer Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US